Skip to main navigation Skip to search Skip to main content

Risperidon ISM®: innovative Depotformulierung zur Therapie der Schizophrenie

Translated title of the contribution: Risperidone ISM® – an innovative long-acting formulation for the treatment of schizophrenia
  • Hans Jörg Assion
  • , Thomas Aubel
  • , Göran Hajak
  • , Stephan Heres
  • , René Hurlemann
  • , Kai Uwe Kühn
  • , Karolina Leopold
  • , Dan Rujescu
  • , Nenad Vasic
  • , Thomas Wobrock
  • , Stefan Leucht
  • LWL-Klinik Dortmund
  • Kliniken Essen-Mitte
  • Klinikum Bamberg
  • Kbo-Klinik für Psychiatrie und Psychotherapie Nord
  • Universität Oldenburg
  • LVR-Klinik Bonn
  • Universitätsklinikum Carl Gustav Carus Dresden
  • Allgemeines Krankenhaus
  • Klinikum Christophsbad
  • University Medical Center

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Risperidone ISM® – an innovative long-acting formulation for the treatment of schizophrenia: innovative Depotformulierung zur Therapie der Schizophrenie'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science